explore -WSS

explore

author：explore 2025-09-07 04:04:38 - browse：1679

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： GSK to buy asthma

leisure time

WSS

Eli Lilly’s Mounjaro succeeds in second weight

Biotech reporter’s notebook: A sunnier mood at JPM 2024

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Xenotransplantation trials will require adjusting expectations, experts say

How to fix the rural physician shortage in the U.S.

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

entertainment

explore

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Can medical device makers keep up in the race to treat obesity?

Hepatitis C has a cure — but many Americans still lack access to it

The thinking behind the controversial eating disorder chatbot Tessa

United colonoscopy coverage change 'may cost lives,' doctors say

Novo pauses ads for weight loss drug Wegovy amid demand

How to save PrEP access — and even expand it

Novo pauses ads for weight loss drug Wegovy amid demand

A public health expert passes on football's full body collisions for youths

hotspot

JPM 2024: Verve Therapeutics looks to mainstream genome editing

The thinking behind the controversial eating disorder chatbot Tessa

The thinking behind the controversial eating disorder chatbot Tessa

The SUPPORT Act is critical to fighting the opioid crisis

Caregivers of transplant patients call for more support, training

Millions may soon lose Medicaid when they don't have to

entertainment

hotspot

leisure time

hotspot